Temasek Holdings’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Temasek Holdings’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,535	Closed	-$3.59M	–	92
2023 Q2	$3.59M	Hold	16,535	–	–	0.02%	58
2023 Q1	$3M	Sell	16,535 -4,015	-20%	-$768K	0.02%	58
2022 Q4	$4.04M	Sell	20,550 -20,548	-50%	-$4.41M	0.02%	60
2022 Q3	$9.24M	Buy	+41,098	New	+$8.32M	0.06%	58
2021 Q4	–	Sell	-12,844	Closed	-$1.57M	–	106
2021 Q3	$1.57M	Hold	12,844	–	–	0.01%	82
2021 Q2	$1.46M	Buy	12,844 +6,422	+100%	+$751K	﹤0.01%	93
2021 Q1	$772K	Buy	+6,422	New	+$728K	﹤0.01%	68

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Temasek Holdings's KRTX Position: Q3 2023 in Review

Temasek Holdings sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 16,535 shares — an estimated $3.59M sold.

Temasek Holdings first reported a position in KRTX in Q1 2021 and held it in 7 quarters. The position peaked at $9.24M in Q3 2022. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

Temasek Holdings reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Temasek Holdings sold 16,535 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.59M.
Temasek Holdings first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Temasek Holdings's Karuna Therapeutics, Inc. Common Stock position peaked at $9.24M in Q3 2022.
256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Temasek Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.